MedPath

microRNA Expression in Renal Cell Carcinoma

Completed
Conditions
Carcinoma, Renal Cell
Registration Number
NCT00743054
Lead Sponsor
Sun Yat-sen University
Brief Summary

In this study, renal cell carcinoma (RCC) related miRNA and the target genes of related miRNA will be examined in order to investigate the role of miRNA in the formation of RCC and look for the biomarker of RCC.

Detailed Description

Due to the lack of specific indicators for the early diagnosis of RCC, the RCC patients often have distant metastasis when diagnosed and their five-year survival rate is much low. Therefore, the biological markers of RCC are needed for early detection, early treatment and improvement of the survival rate of RCC patients.

MiRNA and tumor are closely related. MiRNA can control the important cancer-related genes and participate in the tumor cell proliferation, apoptosis, invasion and angiogenesis.

In this study, RCC related miRNA and the target genes of related miRNA will be examined,and the relationship between RCC related miRNA and the RCC pathological types, TNM (tumor-nodes-metastasis) stages and prognosis will be analyzed. The purpose of this study is to investigate the role of miRNA in the formation of RCC and look for the biomarker of RCC.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Patients with primary renal cell carcinoma.
  • Subjects who agree to participate in the study and sign the informed consent.
Exclusion Criteria
  • Patients with secondary renal cell carcinoma.
  • Subjects who refuse to participate in the study and sign the informed consent.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

The 1st Affiliated Hospital, Sun Yet-sen University

🇨🇳

GuangZhou, Guangdong, China

© Copyright 2025. All Rights Reserved by MedPath